In diabetic patients, haematological alterations are
associated with the production of reactive oxygen species (ROS) as a
consequence of long-term hyperglycemia. This chapter examines the beneficial
effects of biophotonic therapy on hematologic parameters, with particular
emphasis on its relevance to diabetes management. Sunlight, a primary natural
source of photonic energy, has historically been associated with healing
processes, including relief from infections, support of wound repair, and
enhancement of general vitality. Although the molecular mechanisms underlying
photon-mediated therapies remain incompletely defined, emerging evidence
suggests that UV-derived light can modulate immune responses, inhibit microbial
replication, and improve peripheral tissue oxygenation. The complex immunologic
effects of UV exposure include both vitamin D–mediated immune support and, in
excessive doses, immunosuppressive changes accompanied by DNA damage. Notably,
biophotonic interventions have been linked to reductions in HbA1c
concentrations, representing a potentially significant advance in diabetic
care. These effects may stem from the photodissociation of oxygen from
oxyhemoglobin, resulting in enhanced oxygen availability and improved tissue
regeneration. Collectively, the chapter highlights the therapeutic promise of
biophotonic approaches as adjunctive strategies for improving hematologic
function and metabolic outcomes in individuals with diabetes.
Author(s) Details
Orien L. Tulp
Colleges of Medicine and Graduate Studies, University of Science, Arts and
Technology, Montserrat.
Syed A. A. Rizvi
Colleges of Medicine and Graduate Studies, University of Science, Arts and
Technology, Montserrat and Larkin Hospital, Miami FL, USA.
George P Einstein
Colleges of Medicine and Graduate Studies, University of Science, Arts and
Technology, Montserrat.
Please see the book here :- https://doi.org/10.9734/bpi/msup/v6/6845
No comments:
Post a Comment